Non compliance psychotherapeutic in patients of a Service of Mental Health;Incumplimiento psicoterapéutico en pacientes de un equipo de salud mental

Anales de Psiquiatria

Volumn 20, Issue 9, 2004, Pages 392-399

  Dorado Primo, J A ^a,c   Balmon Cruz C ^b  

^a Complejo Hospitalario de Jaén ^*  (Spain)

^b Centro de Salud Levante Sur

^c Equipo Salud Mental   (Spain)

Author keywords

Ambulatory care; Mental health service; Non compliance psychoterapeutic

Indexed keywords

AMBULATORY CARE; ANTISOCIAL BEHAVIOR; ARTICLE; CLINICAL RESEARCH; DATA ANALYSIS; DEMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; PATIENT INFORMATION; PRESCRIPTION; PSYCHOPHARMACOLOGY; SEX DIFFERENCE; SOCIAL ASPECT;

EID: 10644245993     PISSN: 02130599     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Mazziotta JC. Mapping mental illness. A new era. Arch Gen Psychiatry 1996; 53: 574-6.
2. Berman RM, Narasimhan M, Miller H, et al. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Pychiatry 1999; 56: 395-403.
3. Üstun TB. The global burden of mental disorders. Am J Publ Health 1999; 89: 1315-8.
4. Williams A, Friedland G. Adherence, compliance and HAART. AIDS Clin Care 1997; 9: 51-8.
5. Lehtinen V, Rikonen E, Lahtinen E. Promotion of mental health on the European Agenda. Report. Helsinki, Finnish Ministry of Social Affaires and Health. Dpt for Prevention and Promotion, 2000.
6. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998; 49: 196-201.
7. Franch Valverde JI, Conde López VJ, Blanco Garrote JA, et al. El incumplimiento terapéutico: concepto, magnitud, factores relacionados, métodos de detección y medidas de actuación. II Congreso virtual de Psiquiatría Interpsiquis 2001.
8. Haynes RB, Taylor DW, Sackett DD. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.
9. Muehrer P. Research on adherence, behavior change, and mental health: a workshop overview. Health Psychol 2000; 19: 304-7.
10. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 1997; 50: 385-91.
11. Altice FL, Friedland FH. The era of adherence to HIV therapy. Ann Intern Med 1998; 129: 503-5.
12. Dobkin JF. You say "adherence", I say "compliance". Infect Med 1998; 15: 11-65.
13. Codina C, Knobel H, Miró JM, et al. Adherencia al tratamiento antiretroviral. Farm Hosp 1999; 23: 215-29.
14. Lingam R, Scott J. Treatment non-adhrence in affective disorders. Acta Psychiatr Scand 2002; 105: 164-72.
15. Noble L. Doctor-patient communication and adherence to teatment. In: Myers L, Mdence K. Eds. Adhrence to treatment in medical condition. London: Wiley 1998. p. 51-82.
16. Cheever LW, Wu AW. Medication adherence among HIV-infected patients: understanding the complex behavior of patiens taking this complex therapy. Curr Infect Dis Rep 1999; 1: 401-7.
17. Roca B, Gómez CJ, Amedo A. Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced patients. J Infect Dis 2000; 41: 50-4.
18. Blackwell F. Treatment adherence. Br J Phychiat 1976; 129: 513-7.
19. Penzo W. Licenciatura. Psicología Médica. Serie Manuales Básicos. Barcelona: Salvat, 1990. p. 15.
20. Meredith LH, Jackson-Triche M, Duan N, et al. Quality improvement for depression enhances long-term treatment knowledge for primary care clinicians. J Gen Intern Med 2000; 15: 868-77.
21. Spigset O, Martensson B. Drug treatment of depression. Br Med J 1999; 318: 1188-91.
22. Edlund MJ, Wnag PS, Berglund PA, et al. Abandono del tratamiento en salud mental. Am J Psychiatry 2002; 159: 845-51.
23. Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry 2001; 62 (Supl. 16): 5-9.
24. Parra Vázquez C, Rodríguez González-Moro JM, Orero González A, et al. Incumplimiento terapéutico. Madrid: PBM, 2003.
25. Zygmunt A, Olfson M, Boyer C, et al. Intervenciones para mejorar el cumplimiento de la toma de medicación para la esquizofrenia. Am J Psychiatry 2002; 159: 1653-64.
26. Magura S, Laudet AB, Mahmood D, et al. Cumplimiento terapéutico y participación en grupos de autoayuda de patologfa dual. Psychiatric Services 2002; 53: 310-6.
27. Dorado Primo JA, Balmon Cruz C, et al. Análisis de la demanda en el ESM de Andújar: evolución y estudio comparativo a los 20 años de apertura. Revista AEN 2002; XXII (84): 141-54.
28. Salvador Carulla L, Melgarejo Ochoa M. Cumplimiento terapéutico. Barcelona: Ars Médica, 2002.
29. Sackett DL, Haynes RB, Guyatt GH, et al. Epidemiología clínica. Ciencia básica para la medicina clásica. Buenos Aires: Médica Panamericana, 1994.
30. Masur FT. Adherence to health care regimens. En: Prokop & Bradley, eds. Medical psychology. Contribution to behavioral medicine. Academic Press 1441-70981.
31. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999; 18; 13: 1099-107.
32. Tuldrá A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Synd 2000; 25: 221-8.
33. OMS. The World Health Report 1999. Making a difference. Genève: OMS, 1999.
34. Pampallona S, Bollini P, Tibaldy G. Patient adherence in the treatment of depression. Br J Psychiatry 2002; 180: 104-9.
35. Crisp AH, Gelder MG, Rix S, et al. Stigmatisation of people with mental illness. Br J Psychiatry 2000; 177: 4-7.
36. Lin E. The role of the primary care physician in patients adherence toantidepressant therapy. Med Care 1995; 33: 67-74.
37. Katon W, Von Korf M, Lin E. Stepped collaborative care for primary care patients with persistent symptoms of depression. Arch Gen Psychiatry 1999; 56: 1109-15.
38. David MJ. Inform Pharmacother 2001.
39. Franco Ruiz ML, Martínez García S, Correas Lauffer J, et al. Cumplimiento terapéutico y diagnóstico. Comunicación VII Congreso Nal. Psiquiatría. Palma de Mallorca, 2003.
40. Hummer M, Fleischhacker W. Compliance and outcome in patients trated with antipsychotics. CNS Drugs 1996; 5 (Supl. 1): 13-20.
41. Kissling W. Directrices para la prevención de recidivas en la esquizofrenia con neurolépticos. Barcelona: Spinger-Verlag Ibérica, 1994.
42. Mojtabai R, Lavelle J, Gibson PJ, et al. Interrupciones en el uso de antipsicóticos después del alta por primer ingreso en pacientes con esquizofrenia, desde 1989 a 1996. Psychiatric Services 2002; 1: 118-20.
43. Menzin J, Boulanger L, Friedman M, et al. Cumplimiento del tratamiento asociado con antipsicóticos convencionales y atípicos. Psychiatric Services 2003; 54: 719-23.
44. Velligan DI, Lam F, Ereshefsky L, et al. Psicofarmacología: perspectivas sobre el cumplimiento de la medicación y del tratamiento con antipsicóticos atípicos. Psychiatric Services 2003; 54: 665-7.
45. Villalba Quintana E, Alises Valdelomar R, Urretavizcaya M, et al. Uso y del tratamiento con antidepresivos en Atención Primaria en España. Libro blanco en depresión. Madrid: SCM, 2003.
46. Greden JF. Tratamiento de la depresión recidivante. Barcelona: Ars Médica, 2003.